Crossref
Tamoxifen-associated endometrial cancer: key predictors and monitoring
Akusherstvo i ginekologiia · 30.04.2026 · 4_2026 · 52-58
DOI: 10.18565/aig.2026.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Akusherstvo i ginekologiia, erschienen am 30.04.2026. Verfasst von Ivanov I.A. Ivanov und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ivanov, I. I., Ermakova, E. E., & Vislinskaya, V. D. (2026). Tamoxifen-associated endometrial cancer: key predictors and monitoring. Akusherstvo i ginekologiia, 4_2026, 52-58. https://doi.org/10.18565/aig.2026.16
Vancouver
Ivanov II, Ermakova EE, Vislinskaya VD. Tamoxifen-associated endometrial cancer: key predictors and monitoring. Akusherstvo i ginekologiia. 2026;4_2026:52-58. doi:10.18565/aig.2026.16
BibTeX
@article{Ivanov2026,
author = {Ivanov, Ivanov I.A. and Ermakova, Ermakova E.I. and Vislinskaya, Vislinskaya D.D.},
title = {Tamoxifen-associated endometrial cancer: key predictors and monitoring},
journal = {Akusherstvo i ginekologiia},
year = {2026},
volume = {4_2026},
pages = {52--58},
doi = {10.18565/aig.2026.16}
}
EUVIMED